@alphaclubsupps's testicular atrophy claims, fact-checked

What did @alphaclubsupps actually say?

The creator responds to a question about testicular atrophy on 200mg testosterone per week. Their answer: you have two options, HCG or enclomiphene (which they call "Enclomafine"), and "both essentially do the same thing" by protecting fertility and preventing testicular atrophy. They say HCG works directly on the testes, enclomiphene works through the brain first, but "ultimately the result is the same." They add a personal preference for enclomiphene and invite viewers to comment for more TRT guidance.

The core claim is a straightforward comparison of two legitimate clinical interventions. No dosing is given, no disease cure is claimed, and the mechanism descriptions are at least partially accurate. That said, the phrase "result is the same" does real damage to nuance that matters clinically.

Does the science back this up?

Partially, yes. HCG mimicking LH at the testes is well-established. Enclomiphene's mechanism at the hypothalamic-pituitary axis is also real. But the claim that outcomes are equivalent is not supported by the current evidence base.

HCG (human chorionic gonadotropin) binds directly to LH receptors on Leydig cells in the testes, stimulating intratesticular testosterone and supporting spermatogenesis. This is documented in multiple endocrinology contexts. A 2005 study by Coviello et al. in the Journal of Clinical Endocrinology and Metabolism confirmed that low-dose HCG co-administered with testosterone maintained intratesticular testosterone levels that would otherwise decline sharply on exogenous T alone.

Enclomiphene is a selective estrogen receptor modulator that blocks estrogen feedback at the hypothalamus and pituitary, which increases GnRH and subsequently LH and FSH output. A 2013 trial by Kim et al. in BJU International showed enclomiphene raised LH and testosterone in hypogonadal men without suppressing spermatogenesis. But this was in men not already on exogenous testosterone, which is a significant difference from the TRT context the creator is describing.

What did they get wrong (or right)?

They got the mechanisms broadly right. The framing of HCG as working "directly at the testes" and enclomiphene as signaling "the brain first" is a reasonable lay summary of two genuinely different pharmacological pathways. Credit where it is due.

What they got wrong is the equivalence claim. Saying the result is "the same" glosses over a real limitation of enclomiphene in a TRT context. When a man is on exogenous testosterone at 200mg per week, his hypothalamic-pituitary axis is suppressed by the high circulating androgen levels. Enclomiphene works by blocking estrogen feedback at that axis, but if the axis is already blunted by supraphysiologic testosterone, the drug has less machinery to work with. HCG bypasses that suppression entirely by acting directly on the testes. This is not a minor technical footnote. For men on higher-dose TRT, the two options are not interchangeable, and a blanket "same result" claim could lead someone to choose the less effective option for their specific situation.

The creator also mispronounces enclomiphene throughout, calling it "Enclomafine." That is a minor point, but in a space where viewers may be searching for this drug or discussing it with a doctor, it matters.

What should you actually know?

Testicular atrophy on TRT is real and common. Exogenous testosterone suppresses the HPG axis, reducing LH and FSH, which causes the testes to shrink and reduces intratesticular testosterone, sperm production, and fertility. This is not cosmetic. It has functional consequences for anyone who cares about fertility or long-term hormonal health.

HCG is the more established option in a TRT co-administration context, specifically because it bypasses pituitary suppression. Enclomiphene has emerging evidence but most of its trial data comes from men not on concurrent testosterone therapy. The two drugs have different pharmacological leverage points, and which one works better for a given person depends on their protocol, dose, and goals.

Both options require a prescription and monitoring. Neither is without side effects. HCG can raise estradiol; enclomiphene can too, by a different route. Anyone on TRT asking this question should be having it with a licensed clinician who can review their bloodwork, not making decisions based on a 60-second TikTok. The creator's core message that options exist is fair. The claim that they produce the same result is where the video oversimplifies to the point of being potentially misleading.